First in Asia | HOTMAN™️System A Non-invasive Artificial Intelligence Guided Cardiovascular Technology

Cardiovascular diseases

No. 1 cause of death globally, taking an estimated 17.9 million lives each year. 

COVID-19 pandemic

1/3 of the patients who had died had heart diseases and more than 75% of them had hypertension or high blood pressure. 

Singapore

1 in every 3 died of cardiovascular diseases in 2019.

HOTMAN™️(Hemodynamics and Oxygen Transport MANagement) System, developed by Dr B Bo Sramekin 1980. In 1986, NASA invited Dr Sramekto become the Principal Investigator.

Developedto monitor astronauts’ blood pressure and heart performance prior to space missions since 1983. 

  • Unique technology matches the Intensive Care Unit’s grade to provide detailed cardiovascular profiles. 
  • Performs preventive cardiovascular examinations, circulatory system and cardiac function assessments for adults, sports enthusiasts, business executives and patients.

Non-invasive Artificial Intelligence cardiovascular health screening services

  • Exclusive to Harmony Lifecare in Asia
  • Endowed with *TEBCO, +NCCOM3 and certified by FDA, CE and TUV, holding US Patents: 5.503.157 and 5.529.072.

*TEBCO : Thoracic Electrical Bioimpedance Cardiac Output 

+NCCOM3 : NoninvasiveContinuous Cardiac Output Monitor

Smart AI technology

Able to reveal the main reasons that affect your cardiovascular health and cardiac function performance.

Early detection

High blood pressure, stroke, heart failure and other heart related diseases.

Painless–Screening process

Screening process only takes 30 minutes and report is generated almost immediately.
HOTMAN SCREENING EXECUTIVE PACKAGE 行 COMP
RE-HENSIVE Package
Supreme Package
• Cardiac Output (CO)
心输出量
     
• Cardiac Index (CI)
心脏指数
     
• Stroke Volume (SV)
心膊量
     
• Stroke Index (SI)
心膊率
     
• Heart Rate (HR)
心率
     
• Systolic Blood Pressure (SBP)
收缩压
     
• Diastolic Blood Pressure (DBP)
舒张压
     
• Mean Arterial Pressure (MAP)
平均动脉压
     
• Systematic Vascular Resistance (SVR)
循理系统中血管所受的阻力
     
• Left Stroke Work (LSW)
左心脏工作
   
• Left Stroke Work Index (LSWI)
左 心脏 工作除身 体表面面积
   
• Dynamic
动力学比率
   
• Tension
弹性比率
   
• MAP/ SI Hexagonal Graph
状态图表
   
• Thoracic Fluid Conductivity (TFC)
胸液傅 導
   
• Stroke Volume Variation (SVV)
心搏 动变 化率
   
• Pre Ejection Period ( ms ) (PEP)
射血前期
   
• Ejection Fraction (EF)
射血分数
   
• Chronotropy
心率变率性比率
 
• Volemia
血管容积比率
 
• Vasoactivity
血管弹性比率
 
• Inotropy
收缩变力性比率
 
• Stroke Systematic Vascular Resistance (SSVR)
全身血管阻力
 
• Stroke Systematic Vascular Resistance Index
(SSVRI) 全身血管阻力除身 体 表面 面积
 
• Post Examination Review by Doctor 医生后复检查      

PRE-SCREENING INSTRUCTIONS

  • 2-hours before screening, please reduce physical activities and DO NOT CONSUME alcohol, coffee, tea, dark chocolate, cocoa and drugs, as these may affect the results of your test
  • If you are experiencing strong emotions, flu, cold, fever or other illnesses, please postpone the screening
  • It is recommended to do the screening after two weeks of COVID vaccination.
  • Please come in loose-fitting clothing

NOT SUITABLE FOR INDIVIDUAL:

  • under 18-years old 
  • with a pacemaker implant
  • with irregular heartbeats/ Atrial Fibrillation, which may affect the results of the test
  • who are 155kg or more as we will not be able to detect the signal
  • whose Heart Rate is more than 222/ minute
  • Mean Arterial Pressure more than 130 or SBP more than 160